Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam pharmacokinetics before and after bariatric surgery in morbid obesity
NL-OMON39456Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of midazolam in class III obesity (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Difference in midazolam clearance. Started Jan 2012; status: active, not recruiting.
02
Drugs
midazolam
03
Conditions
class III obesity
Beyond the preview
Go deeper on NL-OMON39456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39456.